{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:52:52Z","timestamp":1793213572398,"version":"4.5.0"},"reference-count":203,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001081","name":"The University of Newcastle Hunter Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jneuroim.2025.578755","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:42:20Z","timestamp":1757540540000},"page":"578755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Immunity in Parkinson's disease - the role of adaptive and auto-immune responses and gut-microbiome axis"],"prefix":"10.1016","volume":"409","author":[{"given":"A.R. Satvik","family":"Iyengar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Dunkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2025.578755_bb0005","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/vaccines9070686","article-title":"A possible role for HSV-1-specific humoral response and PILRA rs1859788 polymorphism in the pathogenesis of Parkinson\u2019s disease","volume":"9","author":"Agostini","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0010","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.psyneuen.2012.03.024","article-title":"Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats","volume":"37","author":"Ait-Belgnaoui","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","article-title":"Regulatory impairment in untreated Parkinson\u2019s disease is not restricted to Tregs: other regulatory populations are also involved","volume":"16","author":"\u00c1lvarez-Luqu\u00edn","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0020","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0035","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1523\/JNEUROSCI.1292-12.2012","article-title":"Antibody-aided clearance of extracellular alpha-synuclein prevents cell-to-cell aggregate transmission","volume":"32","author":"Bae","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0040","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.3233\/JPD-191702","article-title":"Gastrointestinal immunity and alpha-synuclein","volume":"9","author":"Barbut","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-5728(00)00422-7","article-title":"Lymphocyte populations in Parkinson\u2019s disease and in rat models of parkinsonism","volume":"113","author":"Bas","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-010-8242-y","article-title":"Immunology, autoimmunity, and autoantibodies in Parkinson\u2019s disease","volume":"42","author":"Benkler","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001376","article-title":"Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons","volume":"3","author":"Benner","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0060","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.2010.226779","article-title":"The microbiota-gut-brain axis: learning from intestinal bacteria?","volume":"60","author":"Bercik","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.664664","article-title":"Autoimmune disorders of the nervous system: pathophysiology, clinical features, and therapy","volume":"12","author":"Bhagavati","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.stem.2018.06.016","article-title":"Th17 cells in Parkinson\u2019s disease: the bane of the midbrain","volume":"23","author":"Bolte","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102684","article-title":"Parkinson\u2019s disease is an autoimmune disease: a reappraisal","volume":"19","author":"Bonam","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","article-title":"Alpha-synuclein misfolding and Parkinson\u2019s disease","volume":"1822","author":"Breydo","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0105","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3389\/fimmu.2018.01133","article-title":"Pro-inflammatory Th1 and Th17 cells are suppressed during human experimental endotoxemia whereas anti-inflammatory IL-10 producing T-cells are unaffected","volume":"9","author":"Brinkhoff","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0110","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0115","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.3233\/JPD-191729","article-title":"Inflammatory bowel diseases and Parkinson's disease","volume":"9","author":"Brudek","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102563","article-title":"Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson\u2019s disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial","volume":"71","author":"Bruggeman","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jneuroim.2016.01.007","article-title":"Humoral cross reactivity between alpha-synuclein and herpes simplex-1 epitope in Parkinson\u2019s disease, a triggering role in the disease?","volume":"291","author":"Caggiu","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fneur.2019.00122","article-title":"Inflammation, infectious triggers, and Parkinson\u2019s disease","volume":"10","author":"Caggiu","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fimmu.2019.00239","article-title":"T-cell-driven inflammation as a mediator of the gut-brain axis involved in Parkinson's disease","volume":"10","author":"Campos-Acuna","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1212\/WNL.41.5_Suppl_2.53","article-title":"The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson\u2019s disease","volume":"41","author":"Carvey","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0145","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebrian","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","article-title":"Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice","volume":"23","author":"Challis","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104587","article-title":"Immunotherapy in Parkinson\u2019s disease: current status and future directions","volume":"132","author":"Chatterjee","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0160","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archneur.55.8.1075","article-title":"Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins","volume":"55","author":"Chen","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0165","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.3892\/mmr.2015.4136","article-title":"Clinical correlation of peripheral CD4+-cell sub-sets, their imbalance and Parkinson's disease","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107988","article-title":"Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle","volume":"231","author":"Chidambaram","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0175","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ni.2635","article-title":"Innate immune recognition of the microbiota promotes host-microbial symbiosis","volume":"14","author":"Chu","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0180","series-title":"A two-part phase 1 study to assess the safety, tolerability, and pharmacokinetics of PDM608 in healthy adult subjects (NCT05950906)","author":"Clinicaltrials.gov","year":"2023"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JPD-202417","article-title":"Expression of transcription factors in CD4 + T cells as potential biomarkers of motor complications in Parkinson\u2019s disease","volume":"11","author":"Contaldi","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0190","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.3233\/JPD-223152","article-title":"T lymphocytes in Parkinson's disease","volume":"12","author":"Contaldi","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042067","article-title":"Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism","volume":"7","author":"Corridoni","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0200","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2006-01-028423","article-title":"Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine\/paracrine inhibitory functional loop","volume":"109","author":"Cosentino","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2982.2010.01664.x","article-title":"The microbiome-gut-brain axis: from bowel to behavior","volume":"23","author":"Cryan","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","article-title":"Th1 and Th17 cells: adversaries and collaborators","volume":"1183","author":"Damsker","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0215","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/pgmj.72.845.164","article-title":"Intestinal permeability and orocaecal transit time in elderly patients with Parkinson\u2019s disease","volume":"72","author":"Davies","year":"1996","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mds.28137","article-title":"CD4+ T-cell transcription factors in idiopathic REM sleep behavior disorder and Parkinson's disease","volume":"36","author":"De Francesco","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0225","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson\u2019s disease: autoimmunity and neuroinflammation","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-022-02605-9","article-title":"The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases","volume":"19","author":"DeMaio","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/NEN.0b013e31820805b9","article-title":"Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease","volume":"70","author":"Depboylu","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.expneurol.2012.08.020","article-title":"Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease","volume":"238","author":"Depboylu","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0245","series-title":"The Interplay between \u03b1-Synuclein and Microglia in \u03b1-Synucleinopathies","first-page":"24","author":"Deyell","year":"2023"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0250","series-title":"Intestinal Barrier Permeability: The Influence of Gut Microbiota, Nutrition, and Exercise","first-page":"15","author":"Dmytriv","year":"2024"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0260","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.expneurol.2009.03.002","article-title":"Anti-melanin antibodies are increased in sera in Parkinson\u2019s disease","volume":"217","author":"Double","year":"2009","journal-title":"Exp.Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0265","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1515\/nipt-2025-0008","article-title":"Adaptive immunity in the pathogenesis and treatments of Parkinson\u2019s disease","volume":"4","author":"Du","year":"2025","journal-title":"NeuroImmune Pharm Ther"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0270","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jnr.24073","article-title":"The role of regulatory T cells in nervous system pathologies","volume":"96","author":"Duffy","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0275","doi-asserted-by":"crossref","first-page":"1104759","DOI":"10.3389\/fneur.2023.1104759","article-title":"Fecal microbiota transplantation in Parkinson\u2019s disease-a randomized repeat-dose, placebo-controlled clinical pilot study","volume":"14","author":"DuPont","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0280","article-title":"Adoptive transfer of mitochondrial antigen-specific CD8+ T-cells in mice causes parkinsonism and compromises the dopamine system","author":"Elemeery","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0285","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3389\/fimmu.2019.02171","article-title":"Protective and regenerative roles of T cells in central nervous system disorders","volume":"10","author":"Evans","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.107681","article-title":"Autoimmune rarities: myasthenia gravis and Parkinson's disease after inflammatory myopathy","volume":"134","author":"Eyig\u00fcrb\u00fcz","year":"2025","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0295","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2019.02.004","article-title":"Mitochondrial antigen presentation: a mechanism linking Parkinson\u2019s disease to autoimmunity","volume":"58","author":"Fahmy","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0300","doi-asserted-by":"crossref","first-page":"14494","DOI":"10.1038\/s41598-023-41182-6","article-title":"Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis","volume":"13","author":"Feng","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0310","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/brain\/awaa269","article-title":"CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease","volume":"143","author":"Galiano-Landeira","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0315","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2019.00303","article-title":"Autoimmunity in Parkinson\u2019s disease: the role of alpha-synuclein-specific T cells","volume":"10","author":"Garretti","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0320","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/B978-0-12-819410-2.00023-0","article-title":"T cells, alpha-synuclein and Parkinson disease","volume":"184","author":"Garretti","year":"2022","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0325","doi-asserted-by":"crossref","first-page":"4784268","DOI":"10.1155\/2018\/4784268","article-title":"Linking neuroinflammation and neurodegeneration in Parkinson's disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0330","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41531-017-0013-5","article-title":"Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson\u2019s disease trial","volume":"3","author":"Gendelman","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0335","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijbiomac.2016.10.021","article-title":"\u0391-Synuclein aggregation and its modulation","volume":"100","author":"Ghosh","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0340","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/aian.aian_1146_23","article-title":"Atypical parkinsonism with positive anti-amphiphysin antibodies: expanding the phenotypic Spectrum","volume":"27","author":"Gomathy","year":"2024","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0345","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","article-title":"T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases","volume":"11","author":"Gonz\u00e1lez","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.07.012","article-title":"Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases","volume":"274","author":"Gonz\u00e1lez","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0355","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/JNN.0000000000000162","article-title":"Understanding Parkinson disease: a complex and multifaceted illness","volume":"47","author":"Gopalakrishna","year":"2015","journal-title":"J. Neurosci. Nurs."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0360","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14728222.2020.1763956","article-title":"The gut-brain axis and gut inflammation in Parkinson\u2019s disease: stopping neurodegeneration at the toll gate","volume":"24","author":"Gorecki","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.929346","article-title":"How do intestinal probiotics restore the intestinal barrier?","volume":"13","author":"Gou","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0370","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fphys.2011.00094","article-title":"Brain-gut-microbe communication in health and disease","volume":"2","author":"Grenham","year":"2011","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0375","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neulet.2011.05.245","article-title":"HLA rs3129882 variant in Chinese Han patients with late-onset sporadic Parkinson disease","volume":"501","author":"Guo","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0380","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ng.642","article-title":"Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease","volume":"42","author":"Hamza","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0385","article-title":"Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera","volume":"7","author":"Han","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0390","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0395","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson\u2019s disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0400","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1006\/exnr.2002.7946","article-title":"Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra","volume":"176","author":"He","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0405","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.3233\/JPD-223153","article-title":"Neuronal presentation of antigen and its possible role in Parkinson\u2019s disease","volume":"12","author":"Hobson","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0410","first-page":"1","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0415","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/brainsci10040206","article-title":"Probiotics alleviate the progressive deterioration of motor functions in a mouse model of Parkinson's disease","volume":"10","author":"Hsieh","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0420","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fphar.2012.00033","article-title":"Aspects of innate immunity and Parkinson\u2019s disease","volume":"3","author":"Huang","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.615075","article-title":"Review: the role of intestinal dysbiosis in Parkinson's disease","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0430","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1038\/s41467-023-38248-4","article-title":"Gut microbiome dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0435","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0440","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson's disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0445","article-title":"Immunity in Parkinson\u2019s disease \u2013 the role of innate responses","volume":"578716","author":"Iyengar","year":"2025","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0450","doi-asserted-by":"crossref","first-page":"14063","DOI":"10.1073\/pnas.0900096106","article-title":"Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration","volume":"106","author":"Jang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0455","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","article-title":"Viral parkinsonism","volume":"1792","author":"Jang","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0460","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3389\/fimmu.2018.02047","article-title":"The challenge of the pathogenesis of Parkinson's disease: is autoimmunity the culprit?","volume":"9","author":"Jiang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0465","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1038\/s41598-020-62756-8","article-title":"Peripheral proinflammatory Th1\/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis","volume":"10","author":"Jin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0470","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0475","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JPD-130250","article-title":"The role of innate and adaptive immunity in Parkinson\u2019s disease","volume":"3","author":"Kannarkat","year":"2013","journal-title":"J. Parkinsons Dis."},{"issue":"627\u2013641","key":"10.1016\/j.jneuroim.2025.578755_bb0480","article-title":"Transneuronal propagation of pathologic alpha-Synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0485","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri.2016.144","article-title":"T cell responses in the central nervous system","volume":"17","author":"Korn","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.10.009","article-title":"GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice","volume":"265","author":"Kosloski","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0495","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00702-012-0842-7","article-title":"Autoimmunity, dendritic cells and relevance for Parkinson\u2019s disease","volume":"120","author":"Koutsilieri","year":"2013","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0500","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1173","article-title":"How T cells \u2018see\u2019 antigen","volume":"6","author":"Krogsgaard","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0505","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.07.021","article-title":"LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation","volume":"229","author":"Kubo","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2016.01.005","article-title":"Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses","volume":"292","author":"Kubo","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-1999-1289","article-title":"MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease","volume":"59","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0520","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0525","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/archneur.56.2.194","article-title":"Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells","volume":"56","author":"Le","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0530","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/gutjnl-2020-322429","article-title":"Inflammatory bowel disease and Parkinson\u2019s disease: common pathophysiological links","volume":"70","author":"Lee","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0535","series-title":"International Parkinson and Movement Disorder Society Conference. Copenhagen, Denmark","first-page":"38","article-title":"Efficacy of a four-strain probiotic on gut dysbiosis, motor and non-motor symptoms in Parkinson's disease: A multicentre randomised controlled trial [abstract]","author":"Leta","year":"2023"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0540","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","article-title":"Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features","volume":"60","author":"Li","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0545","article-title":"Effects of gut microbiota on host adaptive immunity under immune homeostasis and tumor pathology state","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0550","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/MIB.0000000000000735","article-title":"Association between Parkinson\u2019s disease and inflammatory bowel disease: a nationwide Taiwanese retrospective cohort study","volume":"22","author":"Lin","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0555","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","article-title":"Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease","volume":"16","author":"Lin","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0560","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0165-5728(99)00135-6","article-title":"Expression of MHC class I heavy chain and beta2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons","volume":"101","author":"Linda","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0565","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","article-title":"Alpha-synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease","volume":"11","author":"Lindestam Arlehamn","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0570","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1007\/s12035-016-0249-9","article-title":"Th17 cells induce dopaminergic neuronal death via LFA-1\/ICAM-1 interaction in a mouse model of Parkinson\u2019s disease","volume":"54","author":"Liu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0575","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbi.2024.01.010","article-title":"Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: a bench-to-bedside translational approach","volume":"117","author":"Liu","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0580","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s00415-019-09320-1","article-title":"Parkinson\u2019s disease and the gastrointestinal microbiome","volume":"267","author":"Lubomski","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0585","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000539466","article-title":"Association of Autoimmune Diseases with the risk of Parkinson's disease","volume":"59","author":"Ma","year":"2025","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0590","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00018-023-04819-3","article-title":"Intestinal infection triggers mitochondria-mediated \u03b1-synuclein pathology: relevance to Parkinson\u2019s disease","volume":"80","author":"Magalh\u00e3es","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0595","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3389\/fimmu.2019.00969","article-title":"Probiotics may have beneficial effects in Parkinson's disease: in vitro evidence","volume":"10","author":"Magistrelli","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0600","doi-asserted-by":"crossref","first-page":"1348279","DOI":"10.3389\/fcimb.2024.1348279","article-title":"Dysbiosis of the gut microbiota and its effect on \u03b1-synuclein and prion protein misfolding: consequences for neurodegeneration","volume":"14","author":"Mahbub","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0605","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13223-018-0278-1","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0610","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0022-510X(78)90017-5","article-title":"Herpes simplex virus antibodies in patients with Parkinson\u2019s disease","volume":"35","author":"Marttila","year":"1978","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0615","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000114785","article-title":"Viral antibodies in the sera from patients with Parkinson disease","volume":"15","author":"Marttila","year":"1977","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0620","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.1978.00500340044008","article-title":"Herpes simplex virus subunit antibodies in patients with Parkinson\u2019s disease","volume":"35","author":"Marttila","year":"1978","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0625","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-510X(82)90184-8","article-title":"Virus antibodies in Parkinson\u2019s disease. Herpes simplex and measles virus antibodies in serum and CSF and their relation to HLA types","volume":"54","author":"Marttila","year":"1982","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0630","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","article-title":"Parkinson's disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation","volume":"166","author":"Matheoud","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0635","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1332.007","article-title":"Inflammation and the degenerative diseases of aging","volume":"1035","author":"McGeer","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0640","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410240415","article-title":"Rate of cell death in parkinsonism indicates active neuropathological process","volume":"24","author":"McGeer","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0645","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0650","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/BF00689592","article-title":"Expression of the histocompatibility glycoprotein HLA-DR in neurological disease","volume":"76","author":"McGeer","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0655","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2010.03.057","article-title":"The probable relation between toxoplasma gondii and Parkinson\u2019s disease","volume":"475","author":"Miman","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187307","article-title":"Progression of Parkinson's disease is associated with gut dysbiosis: two-year follow-up study","volume":"12","author":"Minato","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0665","series-title":"Microbiome","first-page":"8","author":"Miraglia","year":"2019"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0670","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1017\/S0022029917000620","article-title":"Lactobacilli-fermented cow\u2019s milk attenuated lipopolysaccharide-induced neuroinflammation and memory impairment in vitro and in vivo","volume":"84","author":"Musa","year":"2017","journal-title":"J. Dairy Res."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27113402","article-title":"The role of microbiome in brain development and neurodegenerative diseases","volume":"27","author":"Nandwana","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0680","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host-gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0685","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2202-12-116","article-title":"Neuromelanin is an immune stimulator for dendritic cells in vitro","volume":"12","author":"Oberlander","year":"2011","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0690","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/13550289709015803","article-title":"A rat model of Parkinson\u2019s disease induced by Japanese encephalitis virus","volume":"3","author":"Ogata","year":"1997","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0695","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fmed.2019.00019","article-title":"Gut microbiota and chronic constipation: a review and update","volume":"6","author":"Ohkusa","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0700","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40035-023-00361-1","article-title":"An open-label multiyear study of sargramostim-treated Parkinson\u2019s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers","volume":"12","author":"Olson","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0705","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/brain\/awh625","article-title":"A possible role for humoral immunity in the pathogenesis of Parkinson\u2019s disease","volume":"128","author":"Orr","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0710","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1471-4159.2006.04365.x","article-title":"Autoantibodies to alpha-synuclein in inherited Parkinson\u2019s disease","volume":"101","author":"Papachroni","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0715","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0720","first-page":"1","article-title":"Immune system and Parkinson's disease","volume":"8","author":"Perez","year":"2016","journal-title":"Arch. Med."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0725","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","article-title":"Role of TLR4 in the gut-brain axis in Parkinson\u2019s disease: a translational study from men to mice","volume":"68","author":"Perez-Pardo","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0730","doi-asserted-by":"crossref","first-page":"2418821","DOI":"10.1080\/20565623.2024.2418821","article-title":"CD4+ T-cell transcription factors predict phenoconversion in idiopathic rapid eye movement sleep behavior disorder","volume":"10","author":"Pinoli","year":"2024","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0735","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"Poewe","year":"2017","journal-title":"Parkinson disease. Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0740","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/14728222.2019.1590336","article-title":"Th17 cells: a promising therapeutic target for Parkinson's disease?","volume":"23","author":"Prots","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0745","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1111\/ejn.15192","article-title":"Fecal microbiota transplantation ameliorates gut microbiota imbalance and intestinal barrier damage in rats with stress-induced depressive-like behavior","volume":"53","author":"Rao","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0750","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0140-6736(82)90820-0","article-title":"1918 influenza, encephalitis lethargica, parkinsonism","volume":"2","author":"Ravenholt","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0755","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson\u2019s disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0760","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","article-title":"Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets","volume":"182","author":"Reynolds","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0765","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson\u2019s disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0770","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fneur.2017.00037","article-title":"Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease","volume":"8","author":"Rietdijk","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0775","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.parkreldis.2005.11.004","article-title":"Reversible parkinsonian syndrome associated with anti-neuronal antibodies in acute EBV encephalitis: a case report","volume":"12","author":"Roselli","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0780","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jneuroim.2007.05.011","article-title":"Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration","volume":"188","author":"Rosenkranz","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0785","doi-asserted-by":"crossref","first-page":"1627305","DOI":"10.3389\/fncel.2025.1627305","article-title":"Neuromodulation influences T lymphocyte calcium signaling and alpha synuclein clearance: implications for Parkinson's disease","volume":"19","author":"Ross","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0790","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12974-020-01776-7","article-title":"Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain","volume":"17","author":"Rostami","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0795","first-page":"185","article-title":"Increased intestinal permeability and Parkinson disease patients: chicken or egg? Can","volume":"39","author":"Salat-Foix","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0800","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.3233\/JPD-223278","article-title":"Therapeutic strategies for immune transformation in Parkinson\u2019s disease","volume":"12","author":"Saleh","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0805","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jare.2022.10.013","article-title":"Gut microbiome and Parkinson's disease: perspective on pathogenesis and treatment","volume":"50","author":"Salim","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14785\/lymphosign-2019-0018","article-title":"Microbiota-immune interactions: from gut to brain","volume":"7","author":"Salvo-Romero","year":"2020","journal-title":"LymphoSign J."},{"issue":"1469\u20131480","key":"10.1016\/j.jneuroim.2025.578755_bb0815","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0820","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","article-title":"CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease","volume":"7","author":"Saunders","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0825","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0830","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13024-018-0255-7","article-title":"Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson\u2019s disease","volume":"13","author":"Schutt","year":"2018","journal-title":"Mol. Neurodegener."},{"issue":"123\u2013131","key":"10.1016\/j.jneuroim.2025.578755_bb0835","article-title":"Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease","volume":"23","author":"Sommer","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0840","doi-asserted-by":"crossref","first-page":"2200164","DOI":"10.1002\/mnfr.202200164","article-title":"Roseburia hominis alleviates neuroinflammation via short-chain fatty acids through histone deacetylase inhibition","volume":"66","author":"Song","year":"2022","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0845","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jnutbio.2019.03.021","article-title":"Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity","volume":"69","author":"Srivastav","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0850","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson\u2019s disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0855","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-018-0047-3","article-title":"Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson\u2019s disease","volume":"4","author":"Sulzer","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0860","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson\u2019s disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0865","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1084\/jem.181.6.2161","article-title":"The substantia nigra is a major target for neurovirulent influenza a virus","volume":"181","author":"Takahashi","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0870","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0875","series-title":"New Insights into Immune-Mediated Mechanisms in Parkinson\u2019s Disease","first-page":"21","author":"Tan","year":"2020"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0880","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/jgh3.12450","article-title":"Probiotics for Parkinson\u2019s disease: current evidence and future directions","volume":"5","author":"Tan","year":"2021","journal-title":"JGH Open"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0885","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0890","series-title":"Short-Chain Fatty Acids (except Hexanoic Acid) Lower NF-kB Transactivation, which Rescues Inflammation-Induced Decreased Apolipoprotein A-I Transcription in HepG2 Cells","first-page":"21","author":"Tayyeb","year":"2020"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0895","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0900","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.24901","article-title":"The gut microbiome in human neurological disease: a review","volume":"81","author":"Tremlett","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0905","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1212\/WNL.0000000000002307","article-title":"Hepatitis C virus infection as a risk factor for Parkinson disease: a nationwide cohort study","volume":"86","author":"Tsai","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0910","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3390\/antiox10111823","article-title":"Probiotic enhancement of antioxidant capacity and alterations of gut microbiota composition in 6-hydroxydopamin-induced Parkinson\u2019s disease rats","volume":"10","author":"Tsao","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0915","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0920","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/applmicrobiol3030067","article-title":"The potential role of fecal microbiota transplantation in Parkinson\u2019s disease: a systematic literature review","volume":"3","author":"Vongsavath","year":"2023","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105700","article-title":"Immune responses in the Parkinson's disease brain","volume":"168","author":"Weiss","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0930","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0935","article-title":"PINK1 is a target of T cell responses in Parkinson\u2019s disease","volume":"135","author":"Williams","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0940","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1212\/WNL.55.9.1398","article-title":"Monoclonal antibodies against Epstein-Barr virus cross-react with alpha-synuclein in human brain","volume":"55","author":"Woulfe","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0945","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.parkreldis.2014.02.031","article-title":"Hypothesis: a role for EBV-induced molecular mimicry in Parkinson\u2019s disease","volume":"20","author":"Woulfe","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0950","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/gmic.19320","article-title":"The role of gut microbiota in immune homeostasis and autoimmunity","volume":"3","author":"Wu","year":"2012","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0955","doi-asserted-by":"crossref","first-page":"1007654","DOI":"10.3389\/fphar.2022.1007654","article-title":"Efficacy and safety of probiotics in Parkinson's constipation: a systematic review and meta-analysis","volume":"13","author":"Xie","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0960","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001036","article-title":"Dysregulation of the adaptive immune system in patients with early-stage Parkinson disease","volume":"8","author":"Yan","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0965","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018513","article-title":"Alpha-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson\u2019s disease patients","volume":"6","author":"Yanamandra","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0970","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jconrel.2022.06.024","article-title":"Development of an extended half-life GM-CSF fusion protein for Parkinson\u2019s disease","volume":"348","author":"Yeapuri","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0975","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1034\/j.1600-0404.2002.01240.x","article-title":"Anti-GM1 ganglioside antibodies in Parkinson's disease","volume":"106","author":"Zappia","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0980","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3892\/etm.2021.10974","article-title":"Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson's disease by protecting the function of dopamine neurons","volume":"23","author":"Zhang","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0985","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","article-title":"Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jneuroim.2025.578755_bb0990","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.jneuroim.2025.578755_bb0995","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jneuroim.2025.578755_bb1000","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbi.2020.01.009","article-title":"Regulation of immune-driven pathogenesis in Parkinson's disease by gut microbiota","volume":"87","author":"Zheng","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578755_bb1005","doi-asserted-by":"crossref","DOI":"10.3390\/nu15061518","article-title":"Probiotics supplementation attenuates inflammation and oxidative stress induced by chronic sleep restriction","volume":"15","author":"Zheng","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.jneuroim.2025.578755_bb1010","doi-asserted-by":"crossref","first-page":"14941","DOI":"10.1074\/jbc.M110.211029","article-title":"Phenylbutyrate up-regulates the DJ-1 protein and protects neurons in cell culture and in animal models of Parkinson disease","volume":"286","author":"Zhou","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2025.578755_bb1015","article-title":"Gut microbiota: a novel therapeutic target for Parkinson's disease","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282500236X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282500236X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:42:50Z","timestamp":1766086970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557282500236X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":203,"alternative-id":["S016557282500236X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578755","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunity in Parkinson's disease - the role of adaptive and auto-immune responses and gut-microbiome axis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578755"}}